• Mithra Announces Commercial Launch of Tibelia® in Canada

    Thursday July 30th 2020

  • US Multicenter Study Shows Idylla™ Allows Rapid and Accurate Mutation Testing Results Across Different Laboratory Settings

    Friday June 26th 2020

  • Mithra Signs LSA for Commercialization of Tibelia® in Liechtenstein and Switzerland

    Thursday June 11th 2020

  • Johnson & Johnson Announces Acceleration of its COVID-19 Vaccine Candidate

    Thursday June 11th 2020

  • icometrix lanceert icompanion-platform voor mensen met multiple sclerose

    Tuesday June 2nd 2020

  • argenx Announces Positive Topline Results from Phase 3 ADAPT Trial of Efgartigimod in Patients with Generalized Myasthenia Gravis

    Tuesday May 26th 2020

  • Gilead and Galapagos announce positive topline results of Phase 2B/3 trial of Filgotinib

    Thursday May 21st 2020

  • Mithra and Searchlight Pharma Announce Filing of New Drug Submission for Estelle® in Canada

    Wednesday May 20th 2020

  • Your news here?

  • Progressing Clinical Development of Next Generation Therapies for Diabetic Eye Disease – Beyond anti-VEGF

    Friday May 8th 2020

  • Obesity is linked to gut microbiota disturbance, but not among statin-treated individuals

    Thursday May 7th 2020

  • Imec en Roswell Biotechnologies ontwikkelen biosensorchip voor het snel opsporen van infectieziekten en voor goedkoop uitlezen van DNA

    Wednesday May 6th 2020

Strategic Partners